Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Eukedos SpALTS:0Q8E 32 Days Payable is 851.45 as of Dec. 2025, which is 11% above its 10-year median of 764.43. GuruFocus rates LTS:0Q8E with a GF Score™ of 32/100 and a GF Value™ of €2.60. The stock has 7 warning signs investors should review. Among 607 Healthcare Providers & Services companies, Eukedos SpA ranks better than 96.05% on this metric.
The historical rank and industry rank for Eukedos SpA's Days Payable or its related term are showing as below:
LTS:0Q8E'
s Days Payable Range Over the Past 10 Years
Min: 561.18 Med: 764.43 Max: 1015.03
Current: 889.6
During the past 13 years, Eukedos SpA's highest Days Payable was 1015.03. The lowest was 561.18. And the median was 764.43.
LTS:0Q8E's Days Payable is ranked better than 96.05% of 607
companies
in the Healthcare Providers & Services industry
Industry Median: 57.13
vs LTS:0Q8E: 889.60
Eukedos SpA's Days Payable
declined
from Dec. 2024 (1,002.52) to Dec. 2025 (851.45).
It may suggest that Eukedos SpAaccelerated paying its suppliers.
Eukedos SpA Days Payable Related Terms
Eukedos SpA Days Payable Historical Data
* Premium members only.
The historical data trend for Eukedos SpA's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0Q8E vs HCA, THC, DVA: Days Payable Comparison
For the Medical Care Facilities subindustry, Eukedos SpA's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eukedos SpA Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Eukedos SpA's Days Payable distribution charts can be found below:
* The bar in red indicates where Eukedos SpA's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Eukedos SpA's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eukedos SpA (LTS:0Q8E) has a Days Payable of 851.45 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Eukedos SpA and its competitors. This is 11% above median its historical median of 764.43. Over the past decade, Eukedos SpA's Days Payable has ranged from 561.18 to 1,015.03. According to the industry distribution chart, Eukedos SpA ranks #24 out of 607 companies in the Healthcare Providers & Services industry, placing it in the top 4%.
Is Eukedos SpA's Days Payable too high?
Eukedos SpA's current Days Payable of 851.45 is 11% above median its 10-year median of 764.43. Over the past 10 years, this metric has ranged from a low of 561.18 to a high of 1,015.03. The Healthcare Providers & Services industry median Days Payable is 57.13. Eukedos SpA's value of 851.45 is 1390.4% above this industry median. Based on the distribution chart, Eukedos SpA ranks #24 out of 607 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Eukedos SpA has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Eukedos SpA's Days Payable compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Eukedos SpA ranks #24 out of 607 companies for Days Payable. This places Eukedos SpA in the top 4% of its industry — outperforming the majority of peers. The industry median Days Payable is 57.13. Eukedos SpA's value of 851.45 is 1390.4% above this benchmark. Historically, Eukedos SpA's own Days Payable has ranged from 561.18 to 1,015.03 over the past decade. While the company's 10-year median is 764.43 vs. the industry median of 57.13, Eukedos SpA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 57.13, based on 607 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Eukedos SpA's current Days Payable of 851.45 is 1390.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Eukedos SpA and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 57.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eukedos SpA's current Days Payable is 851.45, which is 11% above median its own 10-year median of 764.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eukedos SpA stock overvalued right now?
Eukedos SpA (LTS:0Q8E) has a current Days Payable of 851.45. The stock's GF Value™ is €2.60, compared to a current price of €1.77 — trading 31.9% below its estimated fair value. The current Days Payable is 851.45, which is 11% above median its 10-year median of 764.43 and 1390.4% above the Healthcare Providers & Services industry median of 57.13. Eukedos SpA's overall GF Score™ is 32/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Eukedos SpA (LTS:0Q8E), the current Days Payable is 851.45 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Eukedos SpA (LTS:0Q8E) Overvalued in 2026?
Based on GuruFocus' analysis, Eukedos SpA stock appears to be undervalued.
The current stock price of €1.77 is trading 31.9% below its estimated GF Value™ of €2.60.
Key valuation signals for LTS:0Q8E:
Days Payable: 851.45 (11% above median its 10-year median of 764.43)
GF Value™: €2.60 vs. price of €1.77 (31.9% below fair value)
Industry Position: 1390.4% above the Healthcare Providers & Services median (#24 of 607)
No single metric tells the full story. See the LTS:0Q8E stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0Q8E has been successfully added to your 
